Response To: Feasibility of a Tumor Progression Model in PRKAR1A-inactivated Melanomas

Am J Surg Pathol. 2021 Jun 1;45(6):869-870. doi: 10.1097/PAS.0000000000001721.

Authors

Jarish N Cohen^{1

2}, Iwei Yeh^{1

2

3

4}, Thaddeus W Mully^{1

2}, Philip E LeBoit^{1

2

3

4}, Timothy H McCalmont^{1

2

3

4}

Affiliations

¹ Departments of Pathology.
² Dermatology.
³ Clinical Cancer Genomics Laboratory.
⁴ Helen Diller Cancer Center, University of California, San Francisco San Francisco, CA.

PMID: 33859070
DOI: 10.1097/PAS.0000000000001721

No abstract available

Publication types

Comment

MeSH terms

Cyclic AMP-Dependent Protein Kinase RIalpha Subunit
Feasibility Studies
Humans
Melanoma* / genetics

Substances

Cyclic AMP-Dependent Protein Kinase RIalpha Subunit
PRKAR1A protein, human